SfN 2026 Posters and Resources
Explore scientific posters presented by the IQVIA Laboratories team at Society for Neuroscience (SfN) annual meeting 2026, Washington, DC, USA.
The Society for Neuroscience annual conference, Neuroscience 2026, took from November 14 to November 18, 2026, at the Walter E. Washington Convention Center in Washington, D.C. During the conference our neuroscience experts shared valuable insights and expertise through eight poster presentations covering in vitro and in vivo models of neurogenerative diseases, epilepsy, migraine and glioma tumors. Explore posters and download your copy below.
Download Scientific Posters
Characterization of Chemically-Induced Migraine Models Using Behavioral and Functional Imaging Readouts
Presented by Jussi Rytkönen, IQVIA Laboratories Kuopio, Finland
DOWNLOAD
Cross-Modality Validation of an iPSC-Derived Blood–Brain Barrier Model Using Small Molecules, Antibodies, and Antisense Oligonucleotides
Presented by Malika Bsibsi, IQVIA Laboratories Leiden, Netherlands
DOWNLOAD
Neurovascular Changes in the DOCA Hypertension Model
Presented by Jussi Rytkönen, IQVIA Laboratories Kuopio, Finland
DOWNLOAD
Advanced Modeling of Amyotrophic Lateral Sclerosis Using a Human iPSC-Derived Motor Neuron, Astrocyte, and Microglia Tri-culture System
Presented by Malika Bsibsi, IQVIA Laboratories Leiden, Netherlands
DOWNLOAD
Modelling Alpha-Synuclein Aggregation and Mitochondrial Dysfunction in a Human iPSC-Derived Dopaminergic Neuron Culture System
Presented by Cindy J.M. Loomans, IQVIA Laboratories Leiden, Netherlands
DOWNLOAD
From Ion Channel Modulation to Network Excitability: A Scalable Integrated Seizure Liability Screening Platform
Presented by Rob Newmans, IQVIA Laboratories Cambridge, UK
DOWNLOAD
Contrast-Enhanced MRI as a Tool for Monitoring Blood–Brain Barrier Leakage in Glioma
Presented by Jussi Rytkönen, IQVIA Laboratories Kuopio, Finland
DOWNLOAD
Low-Mortality Chronic Epilepsy Model Using Fractionated Kainic Acid and Seizure Imaging with Functional Ultrasound
Presented by Jussi Rytkönen, IQVIA Laboratories Kuopio, Finland
DOWNLOAD
Website
Neuroscience Drug Discovery
Combining human-relevant in vitro systems, translational models and pharmacology and deep disease expertise, our neuroscience drug discovery services generate decision-making data from target discovery to candidate selection.
Brochure
Validated Models and Assays for Neuroscience Discovery
This guide provides an overview of validated in vitro and in vivo neuroscience assays, models and readouts across neurodegenerative diseases, pain, injury and ischemia and rare CNS conditions.
Website
Pharmacology and Efficacy Study Methods
Demonstrating therapeutic efficacy requires the right combination of translational models, scientific expertise and experimental technologies. From behavior and motor function, through electrophysiology and in vivo imaging, we employ advanced methods to generate data that supports your critical discovery decisions.
